A team of investigators has begun looking at microRNAs in an entirely new way. Their approach has shown promising results in preclinical models, increasing survival in a murine model of glioblastoma by five-fold when combined with chemotherapy.
A team of investigators has begun looking at microRNAs in an entirely new way. Their approach has shown promising results in preclinical models, increasing survival in a murine model of glioblastoma by five-fold when combined with chemotherapy.